JP2025106309A5 - - Google Patents
Info
- Publication number
- JP2025106309A5 JP2025106309A5 JP2025046395A JP2025046395A JP2025106309A5 JP 2025106309 A5 JP2025106309 A5 JP 2025106309A5 JP 2025046395 A JP2025046395 A JP 2025046395A JP 2025046395 A JP2025046395 A JP 2025046395A JP 2025106309 A5 JP2025106309 A5 JP 2025106309A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- car
- subject
- cells
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962839175P | 2019-04-26 | 2019-04-26 | |
| US62/839,175 | 2019-04-26 | ||
| JP2021563033A JP2022529380A (ja) | 2019-04-26 | 2020-04-24 | キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用 |
| PCT/US2020/029768 WO2020219843A1 (en) | 2019-04-26 | 2020-04-24 | Chimeric antigen receptor constructs and their use in car-t cells |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563033A Division JP2022529380A (ja) | 2019-04-26 | 2020-04-24 | キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025106309A JP2025106309A (ja) | 2025-07-15 |
| JP2025106309A5 true JP2025106309A5 (https=) | 2025-10-27 |
Family
ID=72941305
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563033A Pending JP2022529380A (ja) | 2019-04-26 | 2020-04-24 | キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用 |
| JP2025046395A Pending JP2025106309A (ja) | 2019-04-26 | 2025-03-21 | キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563033A Pending JP2022529380A (ja) | 2019-04-26 | 2020-04-24 | キメラ抗原受容体構築物およびｃａｒ－ｔ細胞におけるそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12479890B2 (https=) |
| EP (1) | EP3959236A4 (https=) |
| JP (2) | JP2022529380A (https=) |
| CN (1) | CN114269777A (https=) |
| WO (1) | WO2020219843A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018050225A1 (en) * | 2016-09-15 | 2018-03-22 | Yu Di | T-cell immunotherapy |
| TW202332765A (zh) * | 2021-09-20 | 2023-08-16 | 美商英麥提克斯股份有限公司 | 用於ｔ細胞療法之ｔ細胞群體的單核球耗盡 |
| KR20250097810A (ko) * | 2022-09-13 | 2025-06-30 | 가부시키가이샤 사이토-팩토 | 이식을 위한 t 세포 및 이의 제조 방법 |
| WO2024236547A1 (en) * | 2023-05-18 | 2024-11-21 | Inceptor Bio, Llc | Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof |
| WO2026047626A1 (en) * | 2024-08-30 | 2026-03-05 | Inceptor Bio, Llc | Compositions and methods involving immune cells engineered for binding bispecific antibodies for use in cell therapy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170241877A1 (en) * | 2002-03-11 | 2017-08-24 | Janusz B. Pawliszyn | System and method for desorbing and detecting an analyte sorbed on a solid phase microextraction device |
| EP3074419B1 (en) * | 2013-11-25 | 2018-08-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric antigen receptors to control hiv infection |
| WO2015092024A2 (en) * | 2013-12-20 | 2015-06-25 | Cellectis | Method of engineering multi-input signal sensitive t cell for immunotherapy |
| US20170335281A1 (en) | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| JP6839074B2 (ja) * | 2014-09-17 | 2021-03-03 | ノバルティス アーゲー | 養子免疫療法のためのキメラ受容体での細胞毒性細胞のターゲティング |
| IL297773B2 (en) | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| EP3233900A2 (en) * | 2014-12-19 | 2017-10-25 | Dana-Farber Cancer Institute, Inc. | Chimeric antigen receptors and methods of use thereof |
| AU2016323985B2 (en) * | 2015-09-17 | 2022-12-15 | Novartis Ag | CAR T cell therapies with enhanced efficacy |
| IL299616A (en) * | 2016-01-08 | 2023-03-01 | Univ California | Conditionally active heterodimeric polypeptides and methods of using them |
| KR20180118175A (ko) * | 2016-03-04 | 2018-10-30 | 노파르티스 아게 | 다중 키메라 항원 수용체 (car) 분자를 발현하는 세포 및 그에 따른 용도 |
| WO2017172952A1 (en) * | 2016-04-01 | 2017-10-05 | Promab Biotechnologies, Inc. | Flag tagged cd19-car-t cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| JP7280827B2 (ja) * | 2017-01-18 | 2023-05-24 | エクスマ バイオテック コーポレイション | Ａｘｌまたはｒｏｒ２に対するキメラ抗原受容体およびその使用方法 |
| CN110615842B (zh) * | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含共刺激受体的嵌合抗原受体及应用 |
-
2020
- 2020-04-24 JP JP2021563033A patent/JP2022529380A/ja active Pending
- 2020-04-24 CN CN202080047342.2A patent/CN114269777A/zh active Pending
- 2020-04-24 US US17/605,890 patent/US12479890B2/en active Active
- 2020-04-24 EP EP20796240.8A patent/EP3959236A4/en active Pending
- 2020-04-24 WO PCT/US2020/029768 patent/WO2020219843A1/en not_active Ceased
-
2025
- 2025-03-21 JP JP2025046395A patent/JP2025106309A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025106309A5 (https=) | ||
| EP4083073A1 (en) | Novel chimeric antigen receptor and use thereof | |
| JP7222600B2 (ja) | 腫瘍細胞に特異的なキメラ抗原レセプター | |
| JP2022529380A5 (https=) | ||
| US20250136697A1 (en) | Methods and compositions comprising b7h3 chimeric antigen receptors | |
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| JP2022542559A5 (https=) | ||
| CN115232209A (zh) | 靶向gprc5d的抗体及其用途 | |
| WO2022247795A1 (zh) | 靶向Claudin18.2的纳米抗体及其用途 | |
| JP2018528786A5 (https=) | ||
| CN113717942A (zh) | 一种联合嵌合抗原受体和i型干扰素的免疫治疗方法及其应用 | |
| CN110461881A (zh) | 嵌合抗原受体 | |
| AU2023415250A1 (en) | Antibody or antibody fragment targeting b7-h3, and use thereof in field of chimeric antigen receptor immune cell therapy | |
| WO2023107593A2 (en) | In vivo delivery to immune cells | |
| WO2022148410A1 (zh) | 抗pd-l1/抗4-1bb天然抗体结构样异源二聚体形式双特异抗体及其制备 | |
| JP2025513626A (ja) | Ｃｉｉｔａ遺伝子がノックアウトされた操作された免疫細胞及びその用途 | |
| CA3158047A1 (en) | Bi-functional antibody against pd-l1 and tgf? | |
| KR20250080888A (ko) | 신규한 항메소텔린 키메라 항원 수용체 및 변형 면역 세포 | |
| JP2024534783A5 (https=) | ||
| US20230270858A1 (en) | Novel co-stimulatory domain and use thereof | |
| Battin et al. | Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents | |
| KR102393776B1 (ko) | Cd22에 특이적인 인간화 항체 및 이를 이용한 키메라 항원 수용체 | |
| CN117430712A (zh) | 靶向cxcr6的嵌合抗原受体及其用途 | |
| CN116600820A (zh) | 嵌合抗原受体(car)间隔子修饰增强car t细胞功能 | |
| CN115873115A (zh) | 一种抗4-1bb单克隆抗体在肿瘤免疫治疗上的应用 |